All Gastrointestinal articles
-
SupplementImproving patient outcomes: supporting pharmacists with the management of pancreatic exocrine insufficiency (PEI)
This supplement has been commissioned, funded, and reviewed by Viatris and developed in partnership with Guidelines for Pharmacy.
Information intended for UK healthcare professionals only.
NON-2021-6348 January 2022 -
Independent professional body guideline
BSG iron deficiency anaemia management guideline
Key recommendations for the assessment and management of iron deficiency anaemia in primary care
-
News
Lyophilised oral faecal microbiota transplantation for ulcerative colitis
Authors of a double-blind, randomised trial suggest that faecal microbiota transplantation could be a promising treatment for patients with ulcerative colitis
-
Video
Diagnosis and initial management of opioid-induced constipation
This promotional video has been funded by Sandoz Ltd and developed in conjunction with Guidelines. The promotional content on this page is intended for UK healthcare professionals only.
View prescribing information
141579 | Date of preparation: September 2021 -
Video
Opioid-induced constipation: optimal management and the role of PAMORA drugs
These promotional videos have been funded by Sandoz Ltd and developed in conjunction with Guidelines. The promotional content on this page is intended for UK healthcare professionals only.
View prescribing information
141578 | Date of preparation: September 2021 -
On demand webinars
The second in a series of half-day virtual events focusing on practical approaches to management of gastrointestinal disorders and iron deficiency
Information intended for UK healthcare professionals only. This promotional event has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines. Promotional information regarding Norgine Pharmaceutical Limited products will be presented during these webinars.
UK-COR-NP-2100090
Date of preparation: October 2021 -
News
FODMAP foods but not gluten affects irritable bowel syndrome symptoms
New research suggests that gluten has no effect on symptoms experienced by patients with IBS, and FODMAPs have a modest effect
-
Concise consultation card
EFFECTIVE MANAGEMENT OF FREQUENT HEARTBURN
This concise consultation card was developed by Guidelines for Pharmacy in partnership with Reckitt.
Essential information and adverse reporting details are included.
RB-M-48260 September 2021 -
News
Does vitamin D supplementation reduce the severity of IBS symptoms? An RCT answers
A new randomised controlled trial found no evidence to support the role of vitamin D in the management of irritable bowel syndrome symptoms or improving quality of life
-
News
NICE publishes C. diff antimicrobial prescribing guideline
The new guideline sets out an antimicrobial prescribing strategy for managing Clostridioides difficile infection in community and hospital settings
-
On demand webinars
Half-day virtual event focusing on practical approaches to management of gastrointestinal disorders and iron deficiency
Information intended for UK healthcare professionals only. This promotional event has been commissioned and funded by Norgine Pharmaceuticals Limited and developed in partnership with Guidelines.
UK-COR-NP-2100043
Date of preparation: July 2021 -
Information
Self Care Forum fact sheets
The Self Care Forum fact sheets help health professionals have a ‘self care aware’ conversation with people about their ailments
-
Independent professional body guideline
Self Care Forum heartburn and indigestion fact sheet
A summary of recommendations for advising patients and the public on managing heartburn and indigestion
-
NICE guideline
NICE CKS on diarrhoea in adults
A summary of NICE guidance on assessing and treating diarrhoea in adults, with recommendations on assessment, dehydration, and referral
-
NICE guideline
COVID-19 rapid guideline on gastrointestinal and liver conditions affecting immune response
A summary of guidance intended to maximise the safety of children and adults with gastrointestinal or liver conditions treated with drugs affecting the immune response during the COVID-19 pandemic
-
NICE guideline
NICE CKS on constipation
Areas covered in the summary include: advice for those with the condition, management (short-duration and chronic), secondary causes of the condition, and prescribing information
-
NICE guideline
NICE pancreatitis guideline
Summary of NICE guidance on pancreatitis covers managing complications, nutrition support, and referral for specialist treatment
-
Guidance card
NICE Technology Appraisal 651: Naldemedine ▼ for treating opioid‑induced constipation
The production and printing of this Guidelines summary card has been commissioned by Sandoz Ltd. Information intended for UK healthcare professionals only.
View prescribing information
UK/P/RZM/20-0016c October 2020 -
Hosted content
The role of peripherally acting µ-opioid receptor antagonists (PAMORAs) in the management of opioid-induced constipation (OIC)
This educational reference document has been initiated, commissioned, and developed by Sandoz Ltd. Information intended for UK healthcare professionals only.
View prescribing information
UK/MKT/RZM/20-0029f October 2020 -
News
Cost of constipation is still rising, reveals new report
A new report from Bowel Interest Group has revealed that the cost of emergency hospital admissions due to constipation continues to rise every year in England
